基于数据的合成蛋白质溶解耐药的激素
Michaela Prothiwa1, Ismail Syed, Mark O Huising
1Department of Chemistry and Chemical Biology, Harvard University , Cambridge, Massachusetts 02138, United States.
Journal of the American Chemical Society
|December 16, 2014
概括
研究人员开发了一种数据驱动的方法,以创建耐蛋白质溶解的类激素类似物. 这一策略成功地产生了一种耐药的oxyntomodulin (OXM) 模拟物prOXM,具有新治疗性类药物的潜力.
科学领域:
- 生物化学 生物化学
- 内分泌学 在内分泌学.
- 药物发现 药物发现 药物发现
背景情况:
- 类激素调节生理学,但由于快速蛋白质分解而面临治疗限制.
- 开发耐蛋白质溶解的类型对于推进基于的治疗方法至关重要.
研究的目的:
- 建立一个数据驱动的合成策略,用于制造抗蛋白质溶解的类激素类似物.
- 将这一策略应用于oxyntomodulin (OXM) 并开发一种耐药的模拟物 (prOXM).
主要方法:
- 利用质谱法识别了oxyntomodulin (OXM) 的血清裂解部位.
- 采用数据驱动合成来创建一种抗蛋白解的OXM模拟物 (prOXM).
- 评估了prOXM在结合,胰岛素分泌和体内葡萄糖调节试验中的活性.
主要成果:
- 确定了OXM的血清裂解部位.
- 合成了prOXM,一种具有与OXM相似的结合和胰岛素分泌活性的蛋白质分解耐药模拟物.
- 证明prOXM有效降低基底葡萄糖水平,并改善小鼠的葡萄糖耐受性.
结论:
- 数据驱动的合成策略是有效的创建蛋白质溶解耐药的类激素类似物.
- prOXM在控制葡萄糖水平方面显示出治疗潜力.
- 这种方法可用于开发其他激素的耐药类型,扩大治疗选择.
相关概念视频
Production of Pharmaceuticals
84
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
84
Insulin: Biosynthesis, Chemistry, and Preparation
2.2K
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
2.2K


